Discontinuation report TARCEVA
| Report ID | 233443 |
| Drug Identification Number | 02269015 |
| Brand name | TARCEVA |
| Common or Proper name | Erlotinib |
| Company Name | HOFFMANN-LA ROCHE LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | ERLOTINIB |
| Strength(s) | 100MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 30 TABS |
| ATC code | L01EB |
| ATC description | |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2024-10-01 |
| Remaining supply date | 2024-10-01 |
| Discontinuation status | To be discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 7070 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 5M8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2024-07-19 | English | Compare |
| v2 | 2024-07-19 | French | Compare |
Showing 1 to 2 of 2